The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
von Willebrand factor and coronary heart disease. Prospective study and meta-analysis
Abstract
AIMS: To determine whether circulating von Willebrand factor concentrations are prospectively related to risk of coronary heart disease in the general population. METHODS AND RESULTS: We measured baseline von Willebrand factor values in the stored serum samples of 625 men with major coronary events and in 1266 controls 'nested' in a prospective study of 5661 men aged 40-59 years, recruited from general practices in 18 British towns in 1978-1980 and followed up for 16 years for fatal coronary heart disease and non-fatal myocardial infarction. We conducted a meta-analysis of previous relevant studies to place our results in context. Men in the top third of baseline von Willebrand factor values (tertile cutoff >126 IU.dl(-1)) had an odds ratio for coronary heart disease of 1.83 (95% confidence interval 1.43-2.35; 2P <0.0001) compared with those in the bottom third (tertile cutoff <90 IU.dl(-1)), after adjustments for age and town. The odds ratio was little changed after further adjustment for risk factors (1.82, 95% CI 1.37-2.41), and was not significantly different in an analysis restricted to the 404 cases and 1007 controls without baseline evidence of coronary heart disease (odds ratio 1.53, 95% CI 1.10-2.12). A meta-analysis of all relevant population-based prospective studies (including the present study) yielded a combined odds ratio of 1.5 (95% CI 1.1-2.0). von Willebrand factor values were strongly correlated with Helicobacter pylori seropositivity and circulating concentrations of C-reactive protein (2 P<0.0001 for each), but not with smoking, blood lipids, or most other measured risk factors. CONCLUSION: Though circulating von Willebrand factor concentrations may be associated with incident coronary heart disease, further studies are needed to determine the extent to which this is causal.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Tunstall-Pedoe, H., Kuulasmaa, K., Amouyel, P., Arveiler, D., Rajakangas, A. M., & Pajak, A. (1994) · Circulation · doi:10.1161/01.cir.90.1.583 · Cited by 2,263
Danesh, J., Collins, R., Appleby, P., & Peto, R. (1998) · JAMA · doi:10.1001/jama.279.18.1477 · Cited by 2,026
Thompson, S. G., Kienast, J., Pyke, S. D. M., Haverkate, F., & van de Loo, J. C. W. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503093321003 · Cited by 1,821
Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses
Danesh, J. (2000) · BMJ · doi:10.1136/bmj.321.7255.199 · Cited by 1,692
Self-citationPLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION
Hamsten, A., Walldius, G., Szamosi, A., Blombäck, M., Faire, U., Dahlén, G., Landou, C., & Wiman, B. (1987) · The Lancet · doi:10.1016/s0140-6736(87)93050-9 · Cited by 1,474
Chronic infections and coronary heart disease: is there a link?
Danesh, J., Collins, R., & Peto, R. (1997) · The Lancet · doi:10.1016/s0140-6736(97)03079-1 · Cited by 1,211
Clarke, R., Shipley, M., Lewington, S., Youngman, L., Collins, R., Marmot, M., & Peto, R. (1999) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010013 · Cited by 877
Atherosclerosis — An Inflammatory Disease
(1999) · New England Journal of Medicine · doi:10.1056/nejm199906173402418 · Cited by 870
Folsom, A. R., Wu, K. K., Rosamond, W. D., Sharrett, A. R., & Chambless, L. E. (1997) · Circulation · doi:10.1161/01.cir.96.4.1102 · Cited by 731
Thögersen, A. M., Jansson, J.-H., Boman, K., Nilsson, T. K., Weinehall, L., Huhtasaari, F., & Hallmans, G. (1998) · Circulation · doi:10.1161/01.cir.98.21.2241 · Cited by 602
Stehouwer, C. A., Zeldenrust, G. C., den Ottolander, G. H., Hackeng, W. H. L., Donker, A. J. M., & Nauta, J. J. P. (1992) · The Lancet · doi:10.1016/0140-6736(92)91401-s · Cited by 560
British Regional Heart Study: cardiovascular risk factors in middle-aged men in 24 towns.
Shaper, A. G., Pocock, S. J., Walker, M., Cohen, N. M., Wale, C. J., & Thomson, A. G. (1981) · BMJ · doi:10.1136/bmj.283.6285.179 · Cited by 526
McColl, K., Murray, L., El-Omar, E., Dickson, A., El-Nujumi, A., Wirz, A., Kelman, A., Penny, C., Knill-Jones, R., & Hilditch, T. (1998) · New England Journal of Medicine · doi:10.1056/nejm199812243392601 · Cited by 515
von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death.
Jansson, J. H., Nilsson, T. K., & Johnson, O. (1991) · Heart · doi:10.1136/hrt.66.5.351 · Cited by 357
Hemostatic Factors as Predictors of Ischemic Heart Disease and Stroke in the Edinburgh Artery Study
Smith, F. B., Lee, A. J., Fowkes, F. G. R., Price, J. F., Rumley, A., & Lowe, G. D. O. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.11.3321 · Cited by 351
Jager, A., van Hinsbergh, V. W. M., Kostense, P. J., Emeis, J. J., Yudkin, J. S., Nijpels, G., Dekker, J. M., Heine, R. J., Bouter, L. M., & Stehouwer, C. D. A. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.12.3071 · Cited by 288
Thrombogenic Factors and Recurrent Coronary Events
Moss, A. J., Goldstein, R. E., Marder, V. J., Sparks, C. E., Oakes, D., Greenberg, H., Weiss, H. J., Zareba, W., Brown, M. W., Liang, C.-S., et al. (1999) · Circulation · doi:10.1161/01.cir.99.19.2517 · Cited by 280
Factor VIII, ABO blood group and the incidence of ischaemic heart disease
Meade, T. W., Cooper, J. A., Stirling, Y., Howarth, D. J., Ruddock, V., & Miller, G. J. (1994) · British Journal of Haematology · doi:10.1111/j.1365-2141.1994.tb05079.x · Cited by 266
Risk factors for coronary heart disease and acute-phase proteins. A population-based study
Danesh, J. (1999) · European Heart Journal · doi:10.1053/euhj.1998.1309 · Cited by 240
Saito, I., Folsom, A. R., Brancati, F. L., Duncan, B. B., Chambless, L. E., & McGovern, P. G. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-2-200007180-00007 · Cited by 235
von Willebrand Factor: A Marker of Endothelial Damage?
Mannucci, P. M. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.9.1359 · Cited by 219
Danesh, J., & Lewington, S. (1998) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182679800500404 · Cited by 216
A RELIABLE MARKER OF ENDOTHELIAL CELL DYSFUNCTION: DOES IT EXIST?
BLANN, A. D., & TABERNER, D. A. (1995) · British Journal of Haematology · doi:10.1111/j.1365-2141.1995.tb05143.x · Cited by 206
Wiman, B., Andersson, T., Hallqvist, J., Reuterwall, C., Ahlbom, A., & deFaire, U. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.8.2019 · Cited by 203
Whincup, P. H., Mendall, M. A., Perry, I. J., Strachan, D. P., & Walker, M. (1996) · Heart · doi:10.1136/hrt.75.6.568 · Cited by 200
Self-citationFully automated fluorescence assay for determining total homocysteine in plasma.
Refsum, H., Ueland, P. M., & Svardal, A. M. (1989) · Clinical Chemistry · doi:10.1093/clinchem/35.9.1921 · Cited by 196
Standl, E., Balletshofer, B., Dahl, B., Weichenhain, B., Stiegler, H., Hörmann, A., & Holle, R. (1996) · Diabetologia · doi:10.1007/s001250050612 · Cited by 192
Rumley, A., Lowe, G. D. O., Sweetnam, P. M., Yarnell, J. W. G., & Ford, R. P. (1999) · British Journal of Haematology · doi:10.1111/j.1365-2141.1999.01317.x · Cited by 184
Danesh, J., & Lewington, S. (1998) · Journal of Cardiovascular Risk · doi:10.1097/00043798-199808000-00004 · Cited by 176
Lifestyle and Hemostatic Risk Factors for Ischemic Heart Disease
YARNELL, J. W. G., Sweetnam, P. M., Rumley, A., & Lowe, G. D. O. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.1.271 · Cited by 151
Danesh, J., Youngman, L. D., Clark, S., Parish, S., Peto, R., & Collins, R. (1999) · BMJ · doi:10.1136/bmj.319.7218.1157 · Cited by 149
Whincup, P. H., Danesh, J., Walker, M., LENNON, L. T., Thomson, A. G., Appleby, P. N., Hawkey, C. J., & Atherton, J. C. (2000) · Circulation · doi:10.1161/01.cir.101.14.1647 · Cited by 129
Self-citationJansson, J.-H., Nilsson, T., & Johnson, O. (1998) · Heart · doi:10.1136/hrt.80.4.334 · Cited by 100
Haemostatic factors and prediction of ischaemic heart disease and stroke in claudicants
Smith, Rumley, Lee, Leng, Fowkes, & Lowe (1998) · British Journal of Haematology · doi:10.1046/j.1365-2141.1998.00626.x · Cited by 99
Twenty year follow-up of a cohort based in general practices in 24 British towns
Walker, M., Shaper, A. G., LENNON, L. T., & Whincup, P. H. (2000) · Journal of Public Health · doi:10.1093/pubmed/22.4.479 · Cited by 90
Self-citationProthrombin fragment 1+2 is a risk factor for myocardial infarction in treated hypertensive men
Agewall, S., Wikstrand, J., & Fagerberg, B. (1998) · Journal of Hypertension · doi:10.1097/00004872-199816040-00016 · Cited by 53
Blann, A. D. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)00081-6 · Cited by 50
Wong, Y.-K., Sueur, J. M., Fall, C. H. D., Orfila, J., & Ward, M. E. (1999) · Journal of Clinical Pathology · doi:10.1136/jcp.52.2.99 · Cited by 49
Kalaria, V. G., Zaręba, W., Moss, A. J., Pancio, G., Marder, V. J., Morrissey, J. H., Weiss, H. J., Sparks, C. E., Greenberg, H., Dwyer, E. M., et al. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)00785-2 · Cited by 40
von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death
Blann, A., Porter, M., McCollum, C., et al. (1992) · Heart · doi:10.1136/hrt.68.12.635 · Cited by 23
Don't rely on drinking wine to prevent traveller's diarrhoea: Table 1
Cook, K. A., Mead, P. S., & MINTZ, E. D. (1996) · BMJ · doi:10.1136/bmj.312.7031.642b · Cited by 7
Cited by
Danesh, J., Wheeler, J. G., Hirschfield, G. M., Eda, S., Eiriksdottir, G., Rumley, A., Lowe, G. D. O., Pepys, M. B., & Gudnason, V. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032804 · Cited by 2,953
Prepared by: British Cardiac Society, B. H. S. (2005) · Heart · doi:10.1136/hrt.2005.079988 · Cited by 1,216
Biomarkers of Cardiovascular Disease: Molecular Basis and Practical Considerations
Vasan, R. S. (2006) · Circulation · doi:10.1161/circulationaha.104.482570 · Cited by 1,212
Health effects of particulate air pollution: A review of epidemiological evidence
Rückerl, R., Schneider, A., Breitner, S., Cyrys, J., & Peters, A. (2011) · Inhalation Toxicology · doi:10.3109/08958378.2011.593587 · Cited by 653
Particulate Matter Exposure in Cars Is Associated with Cardiovascular Effects in Healthy Young Men
Riediker, M., Cascio, W. E., Griggs, T. R., Herbst, M. C., Bromberg, P. A., Neas, L., Williams, R. W., & Devlin, R. B. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200310-1463oc · Cited by 467
Metadata
- Authors
- Whincup, P.
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-11-15
- Volume
- 23
- Issue
- 22
- Pages
- 1764-1770
- ISSN
- 0195-668X (ISSN-L)
- OpenAlex
- W2146160831
- Cited by
- 271
- References
- 42
- FWCI
- 7.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.